1. Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes. Issue 1 (8th December 2015) Authors: Fulcher, G.; Matthews, D. R.; Perkovic, V.; de Zeeuw, D.; Mahaffey, K. W.; Mathieu, C.; Woo, V.; Wysham, C.; Capuano, G.; Desai, M.; Shaw, W.; Vercruysse, F.; Meininger, G.; Neal, B. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 1(2016) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Once weekly exenatide: efficacy, tolerability and place in therapy. Issue 10 (24th March 2013) Authors: Wysham, C.; Grimm, M.; Chen, S. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 10(2013:Oct.) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗